Emagin Corporation (EMAN) Misses Q4 EPS by 2c, Offers Outlook

Emagin Corporation (NYSE: EMAN) reported Q4 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $5.65 million.

Outlook

“Entering 2016, we are strategically focused on supporting our military business and advancing our presence in the consumer marketplace through our AR and VR technology while enhancing our technology and maintaining a strong balance sheet,” continued Mr. Sculley.

“As we look ahead we are encouraged by several factors, including growth in the US Department of Defense budget for 2016 and 2017 after years of flat to down spending. This growth, combined with continued evolution of our technology, positions us well in the government markets for both better volumes on existing contracts and the potential for new opportunities.

“In our commercial business, we are encouraged by the level of interest from potential well-recognized entities with whom we are in conversation. In concert with these discussions, we are actively meeting with potential partners with high volume manufacturing capability to prepare us to meet expected demand from commercial applications of our displays.

“We are highly focused on returning to profitability from our existing product and services business inclusive of ongoing aggressive funding for advanced R&D as well as heavy investments to support our consumer product development efforts. We look forward to achieving stable revenue performance over the short term while we build on what we achieved in our new business efforts in 2015. Overall, we are very excited about the year ahead as we leverage the momentum we have established to drive shareholder value in 2016,” concluded Mr. Sculley.

For earnings history and earnings-related data on Emagin Corporation (EMAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery